Shom Goel

机构：The University of Melbourne, Peter MacCallum Cancer Centre, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

发表论文 7 篇 · 总被引 40 次 · h-index 2

代表论文

• Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer (2026 · New England Journal of Medicine · 被引 37)
• PATINA: A randomized open label phase III trial to evaluate the efficacy and safety of palbociclib + anti HER2 therapy + endocrine therapy vs anti HER2 therapy + endocrine therapy after induction treatment for hormone receptor positive, HER2-positive metastatic breast cancer (2017 · Annals of Oncology · 被引 2)
• Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer (2026 · npj Breast Cancer · 被引 1)
• Abstract RF4-01: Central Nervous System Outcomes from the Phase III PATINA Trial (AFT-38) (2026 · Clinical Cancer Research)
• Abstract GS3-06: Rb Functions as a Transcriptional Activator of ER Targets Following CDK4/6 Inhibition in Luminal Breast Cancer (2026 · Clinical Cancer Research)
• 422TiP Randomized phase 2 trial of preoperative atirmociclib plus letrozole on Ki-67 tumor expression in HR+/HER2− early breast cancer (2025 · Annals of Oncology)